[
    [
        {
            "time": "2023-03-15",
            "original_text": "Inhibitors' Prospects Strong: 4 Stocks Ruling the Space",
            "features": {
                "keywords": [
                    "JAK Inhibitors",
                    "Prospects",
                    "Strong",
                    "Stocks"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "JAK Inhibitors' Prospects Strong: 4 Stocks Ruling the Space",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "Abbvie/Roche's Leukemia Drugs Combination Gets FDA Approval",
            "features": {
                "keywords": [
                    "Abbvie",
                    "Roche",
                    "Leukemia",
                    "Drugs",
                    "FDA",
                    "Approval"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Abbvie/Roche's Leukemia Drugs Combination Gets FDA Approval",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AbbVie",
            "features": {
                "keywords": [
                    "Zacks",
                    "Analyst",
                    "Blog",
                    "Bristol Myers",
                    "Merck",
                    "Roche",
                    "Lilly",
                    "AbbVie"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AbbVie",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "Abbvie/Roche's Leukemia Drugs Combination Gets FDA Approval",
            "features": {
                "keywords": [
                    "Abbvie",
                    "Roche",
                    "Leukemia",
                    "Drugs",
                    "FDA",
                    "Approval"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Abbvie/Roche's Leukemia Drugs Combination Gets FDA Approval",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "JAK Inhibitors' Prospects Strong: 4 Stocks Ruling the Space",
            "features": {
                "keywords": [
                    "JAK Inhibitors",
                    "Prospects",
                    "Strong",
                    "Stocks"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Inhibitors' Prospects Strong: 4 Stocks Ruling the Space",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]